Korean J Helicobacter Up Gastrointest Res.
2025 Mar;25(1):81-86. 10.7704/kjhugr.2024.0073.
Experts’ Perceptions Regarding Testing for Helicobacter pylori Infection During Upper Gastrointestinal Endoscopy and Subsequent Eradication Therapy
- Kim I
1 - Lee SP2
- Kim JW3
- Kim HU4
- Kim TH5
- Kim SY6
- Kim YJ7
- Moon HS8
- Lee JI9
- Shin WG10
- Ethics & Education Committee of The Korean College of Helicobacter and Upper Gastrointestinal Research1
- Affiliations
-
- 1Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 2Department of Internal Medicine, Hanyang University Seoul Hospital, College of Medicine, Hanyang University, Seoul, Korea
- 3Department of Internal Medicine, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, Korea
- 4Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
- 5Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 6Department of Internal Medicine, Korea University Ansan Hospital, College of Medicine, Korea University, Ansan, Korea
- 7Department of Internal Medicine, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea
- 8Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
- 9Department of Internal Medicine, Chosun University Hospital, College of Medicine, Chosun University, Gwangju, Korea
- 10Department of Internal of Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea
- KMID: 2565569
- DOI: http://doi.org/10.7704/kjhugr.2024.0073
Abstract
- Helicobacter pylori causes gastric cancer and peptic ulcers, and eradication therapy can reduce the incidence of cancer in high-risk groups. In Korea, discrepancies between the reimbursement criteria and clinical guidelines create clinical challenges. This study investigated the perceptions and practices of experts regarding H. pylori testing during upper gastrointestinal endoscopy and any subsequent eradication therapy. An anonymous 8-question survey was conducted among 51 experts attending the 2024 Korean College of Helicobacter and Upper Gastrointestinal Research Summer Workshop. Only 2% of the experts tested all patients. Testing was performed in 54% of patients with a family history of gastric cancer, 32% of those with atrophic gastritis, 42% of those with dyspeptic symptoms, and 62% of those with iron-deficiency anemia. Among patients with suspected infections (based on endoscopic findings) and eligible for selective reimbursement, 82% underwent H. pylori testing. Age did not influence testing decisions for 60% of the experts, and 57% considered factors other than age when deciding on eradication therapy. The practices of the experts varied depending on the patient’s clinical condition and economic burden. Aligning clinical guidelines with the reimbursement criteria is necessary to reduce confusion and ensure appropriate patient care.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Approach to Patients after Successful Eradication of Helicobacter pylori
- Prevention of Gastric Cancer: Helicobacter pylori Treatment
- Indications for Helicobacter pylori Eradication Therapy
- A Case of Intradiverticular Ulcer Bleeding in the Duodenum Treated with Helicobacter pylori Eradication and Conservative Care
- Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
